LOR-220

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameLOR-220

Drug Alias NamePI3K-targeting small molecules (Aptose)antibacterial compounds (Aptose)phosphoinositide-3 kinase-targeting small molecules (Lorus)phosphoinositide-3 kinase-targeting small molecules (Aptose)antibacterial compounds (Lorus) +[8]

ClassificationSmall molecules

Mechanisms of ActionPI3-kinase class I modulators

TargetsPI3-kinase class I

Therapy Area/IndicationsNeoplasmsBacterial Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAptose Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAptose Biosciences Inc

Active IndicationsN/A

Inactive IndicationsNeoplasmsBacterial Infections

Other Information

ATC CodeN/A